House Speaker, Nancy Pelosi (D-Calif.), introduced legislation intended to bring down patient drug costs.
Access to Affordable Cancer Drugs Press Releases
Senate Finance Committee Proposes Capping Medicare Patients’ Out-of-Pocket Prescription Drug Costs in Drug Pricing Bill
Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.
Today the House Energy and Commerce Subcommittee on Health will mark-up a series of bills aimed at reducing patient out-of-pocket costs and preserving access to health care. Specifically, the committee will consider a measure that would exempt patients from having to pay surprise medical bills in most circumstances.
Bipartisan Health Package Offers Path Toward Reducing Patients’ Out-Of-Pocket Costs; Improving Public Health
Today the Senate Health, Education, Labor and Pensions Committee will markup legislation aimed at helping reduce patients’ out-of-pocket health care costs and improving public health. The Lower Health Care Costs Act would exempt patients from having to pay surprise medical bills in most circumstances.
Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.
Television and Digital Ad Campaign Calls on HHS Secretary Azar to Stop Proposed Changes to ‘Six Protected Classes’
The American Cancer Society Cancer Action Network (ACS CAN) launched an ad campaign this week highlighting deep concerns from cancer patients and survivors over the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on their access to critical drug therapies.
New Survey: Utilization Management Delays Cancer Care; Leads to More Stress and Contributes to Worse Outcomes
A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.
Cancer patients, survivors and caregivers will tune into the president’s State of the Union address to see if the president will commit to strengthen the nation's health care system, support life-saving medical research and improve quality of life for patients.
ACS CAN and Nearly 60 Patient Advocacy Groups Send Letter Raising Alarm Over Changes to Medicare Part D Cancer Drug Coverage
On Friday the American Cancer Society Cancer Action Network (ACS CAN) along with nearly 60 other patient advocacy organizations sent a letter to the Department of Health and Human Services (HHS) about how proposed changes to Medicare Part D’s six protected classes could hurt cancer patients’ time
ACS CAN Letter: Proposed Changes to Medicare Drug Coverage Could Delay Cancer Patients’ Access to Treatment
Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department Health and Human Services (HHS) detailing ways in which proposed changes to Medicare Part D’s six protected classes could jeopardize cancer patients’ timely access to drug therapies.